Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

stocktitan.net / Share Newsitem

View, share or embed this newsitem using the details below.

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Shuttle Pharmaceuticals secures $4.5M through public offering to advance cancer drug trials, with $2.3M allocated for Phase II testing of Ropidoxuridine. Learn how this strategic funding impacts drug development timelines.

https://newsreadery.com/go/e9ed57c2199d4630fc52057381c2f8df

Save

Back

Read Full Article